epiglucan and Gastritis--Atrophic

epiglucan has been researched along with Gastritis--Atrophic* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Gastritis--Atrophic

ArticleYear
Studies on the characteristic and activity of low-molecular fragments from zymosan.
    Carbohydrate polymers, 2012, Nov-06, Volume: 90, Issue:4

    Zymosan was hydrolysed with HCl and fractionated by ultrafiltration and dialysis to obtain water-soluble fragments A, B and C. Physical and chemical analyses showed that these fractions are composed primarily of glucose and have molecular weights of 8 kDa, 5 kDa and 2 kDa, respectively. A glycosidic linkage analysis indicated that they are mainly composed of β-1,3-glucans. Fragment A, which has the highest molecular weight, contains approximately 30% β-1,6-linked glucans, but fragment C is almost entirely composed of linear β-1,3-glucan chains. The anti-chronic atrophic gastritis activity experiments showed that fragment A has significant activity, the activity of zymosan is quite low and the activities of fragments B and C are in between those of fragment A and zymosan.

    Topics: Animals; beta-Glucans; Bile; Chromatography, Gel; Chronic Disease; Disease Models, Animal; Gastric Mucosa; Gastritis, Atrophic; Immunization; Inflammation; Molecular Weight; Rats; Rats, Wistar; Swine; Zymosan

2012